Advances in vaccine technology, antibody therapies, and genetic surveillance are giving researchers new tools to fight ...

After decades of stalled progress, new vaccines, treatments and genetic tools are helping scientists protect children and ...

Scientists have created the first new anti-malaria drug in quarter of a century in a bid to cut out resistance to existing treatments. Researchers found their new treatment has a “very high cure rate” ...

NEW YORK — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...

A clinical trial by Menzies School of Health Research (Menzies) published in The Lancet has revealed promising results to reduce malaria relapses, through the broader use of primaquine. Primaquine is ...

A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has ...

Swiss medical authorities have approved the first drug suitable to treat malaria in babies and very young children. Eight African countries that participated in clinical trials are now poised to ...

A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has ...

The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

Artesunate AMIVAS is now available for purchase across Europe and U.K. through Nordic Prime of Denmark. Artesunate AMIVAS, approved by EU Commission and U.K.’s Medicine and Healthcare Product ...

New research published today in Nature warns climate change could substantially increase malaria burden in Africa over the ...

Explore the challenges and progress of the Asia-Pacific region in achieving malaria elimination by 2030 amidst funding issues and treatment resistance.